|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Operating expenses: | |
| General and administrative | |
| Research and development | |
| Total operating expenses | |
| Loss from operations | |
| Other income: | |
| Net gain from change in fair value of derivative liability instrument | |
| Gain from change in fair value of forward contract liability | |
| Amortization of deferred offering cost | |
| Interest income | |
| Other income | |
| Total other income | |
| NET LOSS | |
| Basic net loss per common share | |
| Diluted net loss per common share | |
| Weighted-average common shares outstanding, basic | |
| Weighted-average common shares outstanding, diluted |
Loading...
